[Detection and clinical significance of serum HBeAg and HBeAg/IC during the treatment of chronic hepatitis B patients with lamivudine].
Zhang
Hong
H
Department of Infectious Diseases, First Hospital Affiliated to Xi'an Jiaotong University, Xi'an 710061, China.
Zhang
Shu-lin
SL
Ye
Feng
F
Yang
Qian
Q
D000293:Adolescent; D000328:Adult; D000936:Antigen-Antibody Complex / Q000097:blood*; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D004279:DNA, Viral / Q000097:blood; D005260:Female; D006513:Hepatitis B e Antigens / Q000097:blood* / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics / Q000302:isolation & purification; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D000936:Antigen-Antibody Complex; D000998:Antiviral Agents; D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D019259:Lamivudine